Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $41.04 and traded as low as $36.87. Roche shares last traded at $38.10, with a volume of 3,414,537 shares trading hands.
Wall Street Analyst Weigh In
Several research firms have commented on RHHBY. Sanford C. Bernstein raised shares of Roche to a "strong-buy" rating in a research note on Thursday, January 30th. UBS Group raised Roche from a "hold" rating to a "strong-buy" rating in a report on Thursday, February 13th. Finally, Morgan Stanley started coverage on Roche in a research report on Wednesday, February 12th. They set an "equal weight" rating on the stock. Two research analysts have rated the stock with a sell rating, one has given a hold rating, one has assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Roche has a consensus rating of "Moderate Buy".
Check Out Our Latest Stock Analysis on RHHBY
Roche Stock Performance
The company's 50 day moving average price is $40.95 and its 200-day moving average price is $38.56. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86.
Hedge Funds Weigh In On Roche
A number of hedge funds have recently modified their holdings of RHHBY. Brooklyn Investment Group raised its holdings in Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company's stock worth $48,000 after buying an additional 363 shares during the period. Verity Asset Management Inc. increased its position in shares of Roche by 26.8% in the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock worth $280,000 after acquiring an additional 1,697 shares in the last quarter. HighPoint Advisor Group LLC lifted its position in shares of Roche by 2.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock valued at $387,000 after acquiring an additional 304 shares in the last quarter. Fulton Bank N.A. boosted its stake in Roche by 2.6% in the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after purchasing an additional 314 shares during the period. Finally, GAMMA Investing LLC grew its position in Roche by 59.5% during the 1st quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock worth $529,000 after purchasing an additional 4,794 shares in the last quarter.
About Roche
(
Get Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Articles
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
